A new IL-12 Immunotherapy Study for Dogs with Soft Tissue Sarcoma
$ 25.99
In stock
4.5
(137)
Cancers, Free Full-Text
NK cell-based immunotherapy for malignant diseases
Cells, Free Full-Text
Animals, Free Full-Text
Optogenetic-controlled immunotherapeutic designer cells for post
Tumor-localized interleukin-2 and interleukin-12 combine with
Canine Sarcoma: An Overview of Cancer Immunotherapy
Immunohistological staining of canine IL-12 in tumors. a
Oncolytic virotherapy with intratumoral injection of vaccinia